Authors:
Grabau, DA
Thorpe, SM
Knoop, A
Vach, W
Schroder, HD
Blichert-Toft, M
Al-Suliman, NN
Graversen, HP
Rose, C
Citation: Da. Grabau et al., Immunohistochemical assessment of oestrogen and progesterone receptors: correlations with the DCC method and clinical outcome in primary breast cancer patients, BREAST, 9(4), 2000, pp. 208-217
Authors:
Jorgensen, AS
Jacobsen, P
Christiansen, LB
Bury, PS
Kanstrup, A
Thorpe, SM
Bain, S
Naerum, L
Wassermann, K
Citation: As. Jorgensen et al., Synthesis and pharmacology of a novel pyrrolo[2,1,5-cd] indolizine (NNC 45-0095), a high affinity non-steroidal agonist for the estrogen receptor, BIOORG MED, 10(4), 2000, pp. 399-402
Authors:
Kroman, N
Thorpe, SM
Wohlfahrt, J
Andersen, KW
Mouridsen, HT
Citation: N. Kroman et al., Variations in prognostic factors in primary breast cancer throughout the menstrual cycle, EUR J SUR O, 26(1), 2000, pp. 11-16
Authors:
Andersen, HR
Andersson, AM
Arnold, SF
Autrup, H
Barfoed, M
Beresford, NA
Bjerregaard, P
Christiansen, LB
Gissel, B
Hummel, R
Jorgensen, EB
Korsgaard, B
Le Guevel, R
Leffers, H
McLachlan, J
Moller, A
Nielsen, JB
Olea, N
Oles-Karasko, A
Pakdel, F
Pedersen, KL
Perez, P
Skakkeboek, NE
Sonnenschein, C
Soto, AM
Sumpter, JP
Thorpe, SM
Grandjean, P
Citation: Hr. Andersen et al., Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals, ENVIR H PER, 107, 1999, pp. 89-108